3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Rituximab
7
Vemurafenib
4
Cyclophosphamide
4
Cladribine
4
Specimen Handling
3
Biopsy
3
obinutuzumab
2
ibrutinib
2
fludarabine phosphate
2
fludarabine
2
binimetinib
2
Diphenhydramine
2
Dexamethasone
2
Calcium Dobesilate
2
CT-P10
2
Acetaminophen
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
immunotoxin HA22
1
encorafenib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brexucabtagene autoleucel
1
auricularum
1
acalabrutinib
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Pentetic Acid
×
1 year
×
Clear all
No trials found.